EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 1 of 3 (Hits 1 to 20 of 48)
ID
Country
PT provider
PT scheme
Last changed
138199 United States Collaborative Testing Services Collaborative Testing Services CTS Agriculture Laboratory Proficiency (ALP) Program: Water CTS Agriculture Laboratory Proficiency (ALP) Program: Water 2024-07-18
Tested property (Sum Cations, SAR, ADJ-SAR)

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Tested property (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Testing method (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix)

302644 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Environmental Hygiene Monitoring Scheme- HYGIENE Environmental Hygiene Monitoring Scheme- HYGIENE 2021-09-06
Test item (Surface testing (swab rinsate) for SARS-CoV-2 molecular)
Tested property (SARS-CoV-2)

820055 United Kingdom INSPEC International Limited INSPEC International Limited Personal Protective Equipment [Personal Protective Equipment] Personal Protective Equipment [Personal Protective Equipment] 2024-10-20
Related legislation or standard (European PPE Regulation (EU 2016/425) National legislation regarding PPE for Covid-19)

699949 United Kingdom UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies 2023-05-30
PT name (UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies)
Tested property (SARS-CoV-2 / COVID-19 Antibodies)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2022-05-04
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome)
Testing method (The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.)

925094 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] Molecular detection of SARS-CoV-2 [Molecular detection of SARS-CoV-2] 2022-05-13
PT name (Molecular detection of SARS-CoV-2)
Scheme name in national language (Molecular detection of SARS-CoV-2)
Test item (/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed))
Tested property (SARS-CoV-2 nucleic acid)

1144039 United Kingdom Weqas Weqas POCT Respiratory Virus [POCT Respiratory Virus] POCT Respiratory Virus [POCT Respiratory Virus] 2024-10-01
Remarks (targeted for Influenza A (and subtypes) Influenza B, SARS-Cov-2, and Respiratory Syncytial Virus) (), influenza B, RSV, SARS-Cov-2 or no virus. A range of differing viral loads are distributed including) (reporting for SARS-CoV-2 Ag (RNA), Influenza A, Influenza B and RSV available. For more information)
Tested property (SARS-CoV-2 Ag (RNA))

1217643 United Kingdom UK NEQAS for Microbiology UK NEQAS for Microbiology Respiratory viruses Point of Care [Respiratory viruses Point of Care] Respiratory viruses Point of Care [Respiratory viruses Point of Care] 2024-09-24
Tested property (Detection of antigens /nucleic acid for SARS-CoV-2, influenza and RSV using POCT devices)

143957 United Kingdom Public Health England Public Health England Food and Environmental Proficiency Testing Unit (FEPTU) Food and Environmental Proficiency Testing Unit (FEPTU) 2025-04-15
Tested property (SARS-CoV-2)

883284 Thailand Department of Medical Sciences PT provider (DMSc PT provider) Department of Medical Sciences PT provider (DMSc PT provider) SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] 2024-01-09
PT name (SARS-CoV-2 detection by Real-time RT-PCR)
Scheme name in national language (SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข))

1129430 Spain ielab ielab SARS-CoV-2 [SARS-CoV-2] SARS-CoV-2 [SARS-CoV-2] 2023-11-29
PT name (SARS-CoV-2)
Scheme name in national language (SARS-CoV-2)
Tested property (SARS-CoV-2)

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] 2024-03-13
PT name (SARS-CoV-2, molecular detection)
Scheme name in national language (SARS-CoV-2, molecular detection)
Tested property (SARS-CoV-2 virus)

1271562 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. Virus serology: SARS-CoV-2 [Vírus szerológia: SARS-CoV-2] Virus serology: SARS-CoV-2 [Vírus szerológia: SARS-CoV-2] 2024-10-08
PT name (Virus serology: SARS-CoV-2)
Remarks (The content of the scheme: SARS-CoV-2 antibody (IgG-, IgG-S, IgG-N, IgM, IgA, total antibody)
Scheme name in national language (Vírus szerológia: SARS-CoV-2)
Tested property (Anti-SARS-CoV-2 total (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-S (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-N (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgM (OD, S/CO, quantitative, evaluation))

1271523 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. POCT: SARS-CoV-2 [POCT: SARS-CoV-2] POCT: SARS-CoV-2 [POCT: SARS-CoV-2] 2024-10-08
PT name (POCT: SARS-CoV-2)
Remarks (The content of the scheme: SARS-CoV-2 antibody (IgG, IgM, total antibody) and antigen determination)
Scheme name in national language (POCT: SARS-CoV-2)
Tested property (Anti-SARS-CoV-2 total qualitative) (Anti-SARS-CoV-2 - IgG qualitative) (Anti-SARS-CoV-2 - IgM qualitative) (SARS-CoV-2 Antigen qualitative) (SARS-CoV-2 interpretation)

1271426 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. Virus nucleic acid determination: SARS-CoV-2 [Vírus nukleinsav meghatározás: SARS-CoV-2] Virus nucleic acid determination: SARS-CoV-2 [Vírus nukleinsav meghatározás: SARS-CoV-2] 2024-11-25
PT name (Virus nucleic acid determination: SARS-CoV-2)
Remarks (amplification techniques (NAT) for qualitative determination of SARS-CoV-2 virus. Qualitative results are)
Scheme name in national language (Vírus nukleinsav meghatározás: SARS-CoV-2)

1163321 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] 2024-04-16
Tested property (influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated))

1163304 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] 2024-04-16
Tested property (incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively)

1163345 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] 2024-04-16
PT name (Virus Genome Detection – SARS-CoV-2 sequence analysis (417))
Remarks (Please note: Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2)
Scheme name in national language (Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417))
Tested property (Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing)

1163338 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] 2024-04-16
PT name (Virus Genome Detection – SARS-CoV-2 (409))
Scheme name in national language (Virusgenom-Nachweis - SARS-CoV-2 (409))
Tested property (The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2)

Page 1 of 3 (Hits 1 to 20 of 48)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5